Sinovac Biotech Ltd Financial Flexibility Index
Sinovac Biotech Ltd financial flexibility index. Sinovac Biotech Ltd (SVA) has a Financial Flexibility Index of 0.12x as of December 2023. Free cash flow of $198.75 Million (operating CF $146.01 Million minus capex $52.75 Million) represents 0% of total liabilities ($1.64 Billion). See SVA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sinovac Biotech Ltd (2000–2025)
Financial flexibility index of Sinovac Biotech Ltd from 2000 to 2025. Historical Financial Flexibility Index trend for Sinovac Biotech Ltd across 26 annual periods. Check Sinovac Biotech Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Sinovac Biotech Ltd Financial Flexibility Index by Year (2000–2025)
Sinovac Biotech Ltd financial flexibility index by year from 2000 to 2025. Year-by-year free cash flow to debt coverage for Sinovac Biotech Ltd. For the full cash flow conversion analysis, see SVA cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.21x | $-461.57 Million | $-510.49 Million | $2.23 Billion | ▼ -1138.0% |
| 2024 | 0.02x | $40.70 Million | $-56.89 Million | $2.04 Billion | ▼ -87.1% |
| 2023 | 0.15x | $251.71 Million | $106.02 Million | $1.64 Billion | ▲ +158.7% |
| 2022 | -0.26x | $-367.38 Million | $-770.75 Million | $1.40 Billion | ▼ -104.7% |
| 2021 | 5.60x | $16.07 Billion | $15.35 Billion | $2.87 Billion | ▲ +620.2% |
| 2020 | 0.78x | $606.96 Million | $479.31 Million | $781.20 Million | ▲ +56.5% |
| 2019 | 0.50x | $49.70 Million | $39.07 Million | $100.10 Million | ▲ +185.1% |
| 2018 | 0.17x | $13.56 Million | $7.94 Million | $77.85 Million | ▼ -80.2% |
| 2017 | 0.88x | $71.67 Million | $59.76 Million | $81.69 Million | ▲ +2655.1% |
| 2016 | -0.03x | $-2.81 Million | $-15.46 Million | $81.69 Million | ▼ -124.0% |
| 2015 | 0.14x | $9.51 Million | $4.21 Million | $66.42 Million | ▲ +1663.4% |
| 2014 | 0.01x | $786.00K | $-10.13 Million | $96.80 Million | ▼ -92.6% |
| 2013 | 0.11x | $10.71 Million | $5.58 Million | $97.05 Million | ▲ +9031.7% |
| 2012 | 0.00x | $-98.00K | $-16.25 Million | $79.33 Million | ▼ -100.3% |
| 2011 | 0.42x | $29.39 Million | $13.94 Million | $70.61 Million | ▲ +149.8% |
| 2010 | 0.17x | $11.10 Million | $-14.28 Million | $66.60 Million | ▼ -80.7% |
| 2009 | 0.86x | $52.73 Million | $48.41 Million | $61.01 Million | ▲ +42.1% |
| 2008 | 0.61x | $14.48 Million | $10.50 Million | $23.80 Million | ▲ +120.2% |
| 2007 | 0.28x | $6.78 Million | $4.32 Million | $24.55 Million | ▲ +976.0% |
| 2006 | -0.03x | $-495.31K | $-1.64 Million | $15.70 Million | ▼ -141.6% |
| 2005 | 0.08x | $520.01K | $-1.13 Million | $6.86 Million | ▲ +361.3% |
| 2004 | 0.02x | $112.72K | $-1.54 Million | $6.86 Million | ▲ +106.6% |
| 2003 | -0.25x | $-993.86K | $-1.72 Million | $4.01 Million | ▲ +40.8% |
| 2002 | -0.42x | $-57.25K | $-58.05K | $136.81K | ▲ +18.9% |
| 2001 | -0.52x | $-491.09K | $-494.80K | $952.15K | ▲ +0.0% |
| 2000 | -0.52x | $-491.09K | $-494.80K | $952.15K | — |